The multicenter, phase II prospective study of paclitaxel plus capecitabine as first-line chemotherapy in advanced gastric carcinoma.
Gong J, Hu B, Zhang X, Zhang F, Zhang J, Xu N, Fan Q, Bai Y, Jiao S, Wang J, Bai C, Zheng L, Shi Y, Liu Y, Liang J, Hu G, Cheng Y, Xu R, Bai Y, Shen L.
Gong J, et al. Among authors: zhang f, zhang j, zhang x.
Oncologist. 2014 Feb;19(2):173-4. doi: 10.1634/theoncologist.2013-0137. Epub 2014 Jan 23.
Oncologist. 2014.
PMID: 24457378
Free PMC article.
Clinical Trial.